Page last updated: 2024-11-12

bastadin 4

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10328662
CHEMBL ID453147
CHEMBL ID455487
MeSH IDM0450455

Synonyms (4)

Synonym
bdbm50241983
chembl453147
bastadin-4
CHEMBL455487
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ryanodine receptor 1Homo sapiens (human)EC50 (µMol)14.70002.20002.20002.2000AID334201
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
response to hypoxiaRyanodine receptor 1Homo sapiens (human)
outflow tract morphogenesisRyanodine receptor 1Homo sapiens (human)
calcium ion transportRyanodine receptor 1Homo sapiens (human)
muscle contractionRyanodine receptor 1Homo sapiens (human)
release of sequestered calcium ion into cytosol by sarcoplasmic reticulumRyanodine receptor 1Homo sapiens (human)
calcium-mediated signalingRyanodine receptor 1Homo sapiens (human)
response to caffeineRyanodine receptor 1Homo sapiens (human)
skin developmentRyanodine receptor 1Homo sapiens (human)
ossification involved in bone maturationRyanodine receptor 1Homo sapiens (human)
skeletal muscle fiber developmentRyanodine receptor 1Homo sapiens (human)
release of sequestered calcium ion into cytosolRyanodine receptor 1Homo sapiens (human)
protein homotetramerizationRyanodine receptor 1Homo sapiens (human)
regulation of cytosolic calcium ion concentrationRyanodine receptor 1Homo sapiens (human)
cellular response to calcium ionRyanodine receptor 1Homo sapiens (human)
cellular response to caffeineRyanodine receptor 1Homo sapiens (human)
striated muscle contractionRyanodine receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
ryanodine-sensitive calcium-release channel activityRyanodine receptor 1Homo sapiens (human)
voltage-gated calcium channel activityRyanodine receptor 1Homo sapiens (human)
calcium channel activityRyanodine receptor 1Homo sapiens (human)
calcium ion bindingRyanodine receptor 1Homo sapiens (human)
calmodulin bindingRyanodine receptor 1Homo sapiens (human)
ATP bindingRyanodine receptor 1Homo sapiens (human)
intracellularly gated calcium channel activityRyanodine receptor 1Homo sapiens (human)
calcium-induced calcium release activityRyanodine receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
cytoplasmRyanodine receptor 1Homo sapiens (human)
plasma membraneRyanodine receptor 1Homo sapiens (human)
cell cortexRyanodine receptor 1Homo sapiens (human)
junctional sarcoplasmic reticulum membraneRyanodine receptor 1Homo sapiens (human)
terminal cisternaRyanodine receptor 1Homo sapiens (human)
sarcoplasmic reticulumRyanodine receptor 1Homo sapiens (human)
organelle membraneRyanodine receptor 1Homo sapiens (human)
I bandRyanodine receptor 1Homo sapiens (human)
sarcoplasmic reticulum membraneRyanodine receptor 1Homo sapiens (human)
extracellular exosomeRyanodine receptor 1Homo sapiens (human)
ryanodine receptor complexRyanodine receptor 1Homo sapiens (human)
Z discRyanodine receptor 1Homo sapiens (human)
sarcolemmaRyanodine receptor 1Homo sapiens (human)
smooth endoplasmic reticulumRyanodine receptor 1Homo sapiens (human)
sarcoplasmic reticulum membraneRyanodine receptor 1Homo sapiens (human)
calcium channel complexRyanodine receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1255369Inhibition of human ACAT2 expressed in CHO cells assessed as inhibition of [3H]cholesterol ester accumulation at 5 uM in presence of 0.1 mM [3H]oleate-conjugated BSA2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Bastadins, brominated-tyrosine derivatives, suppress accumulation of cholesterol ester in macrophages.
AID463757Cytotoxicity against human HCT116 cells after 7 days by methylene blue staining2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations.
AID354812Antimicrobial activity against Neisseria gonorrhoeae ATCC 49226 after 16 hrs by disk susceptibility test1996Journal of natural products, Oct, Volume: 59, Issue:10
Isolation and structure of hemibastadinols 1-3 from the Papua New Guinea marine sponge Ianthella basta.
AID334201Displacement of [3H]ryanodine from RyR1 calcium channel in sarcoplasmic reticulum assessed as calcium mobilization2003Journal of natural products, Jan, Volume: 66, Issue:1
Cationic reduction of bastadin-4 to bastadin-5. Preparation of 5-[2h]-bastadin-5 by site-specific isotopic labeling.
AID354814Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 16 hrs by disk susceptibility test1996Journal of natural products, Oct, Volume: 59, Issue:10
Isolation and structure of hemibastadinols 1-3 from the Papua New Guinea marine sponge Ianthella basta.
AID336522Cytotoxicity against mouse L1210 cells
AID354813Antimicrobial activity against Enterococcus faecalis ATCC 29212 after 16 hrs by disk susceptibility test1996Journal of natural products, Oct, Volume: 59, Issue:10
Isolation and structure of hemibastadinols 1-3 from the Papua New Guinea marine sponge Ianthella basta.
AID354815Antimicrobial activity against Candida albicans ATCC 90028 up to 100 ug/disk after 42 hrs by disk susceptibility test1996Journal of natural products, Oct, Volume: 59, Issue:10
Isolation and structure of hemibastadinols 1-3 from the Papua New Guinea marine sponge Ianthella basta.
AID1255368Inhibition of human ACAT1 expressed in CHO cells assessed as inhibition of [3H]cholesterol ester accumulation at 5 uM in presence of 0.1 mM [3H]oleate-conjugated BSA2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Bastadins, brominated-tyrosine derivatives, suppress accumulation of cholesterol ester in macrophages.
AID354816Antimicrobial activity against Cryptococcus neoformans ATCC 90112 up to 100 ug/disk after 42 hrs by disk susceptibility test1996Journal of natural products, Oct, Volume: 59, Issue:10
Isolation and structure of hemibastadinols 1-3 from the Papua New Guinea marine sponge Ianthella basta.
AID1255366Inhibition of ACAT in human MDM cells assessed as inhibition of foam cell formation by measuring acetylated LDL-induced [3H]cholesterol ester accumulation at 5 uM after 24 hrs in presence of 0.1 mM [3H]oleate2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Bastadins, brominated-tyrosine derivatives, suppress accumulation of cholesterol ester in macrophages.
AID1255367Cytotoxicity against human MDM cells at 5 uM after 24 hrs2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Bastadins, brominated-tyrosine derivatives, suppress accumulation of cholesterol ester in macrophages.
AID463756Antitrypanosomal activity against Trypanosoma brucei brucei 221 after 48 hrs by ATP-bioluminescence assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.76 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]